Stroke and atrial fibrillation in a health institution of Quindío

Abstract

Introduction: Atrial Fibrillation (AF) has been frequently related to Cerebrovascular Accident (CVA). Objective: To describe the prevalence of Atrial Fibrillation and its comorbidities in patients of a Cardiovascular Risk program of a health institution (IPS) in Quindío. Material and method: Descriptive cross-sectional study. The medical records of 193 patients with a diagnosis of atrial fibrillation were accessed, with institutional consent. A sample of 53 study subjects was obtained, calculated for a finite population, adjusted for prevalence, randomized, with systematic replacement, if the required information was not available. The prevalence of atrial fibrillation and ischemic stroke, the use of drugs for rate control, rhythm control and anticoagulants, the CHA2-DS2-VASC scale and the risk classification were calculated. Results: Atrial fibrillation prevalence of 5.01% and ischemic stroke of 7.55% were found. Average body mass index (BMI) of 27.44 (± 6.20). Carvedilol was the most used drug (50.94%) for frequency control, amiodarone the most used drug (11.32%) for rhythm control, and rivaroxaban (50.94%) as anticoagulant. Hypertension was identified in 100% of the patients, diabetes in 37.74% and vascular disease in 32.98%, which are variables of the CHA2-DS2-VASC scale with a high prevalence in this population. Conclusions: The prevalence of atrial fibrillation was 5.01% and the prevalence of ischemic stroke was 7.55%. The average score of the CHA2-DS2-VASC scale was 4.26 and 88.68% of the population found in high risk for Ischemic Stroke.